Search

Your search keyword '"Chauhan, Aman"' showing total 238 results

Search Constraints

Start Over You searched for: Author "Chauhan, Aman" Remove constraint Author: "Chauhan, Aman"
238 results on '"Chauhan, Aman"'

Search Results

203. Inhibition of ribonucleotide reductase subunit M2 enhances the radiosensitivity of metastatic pancreatic neuroendocrine tumor.

204. Critical updates in neuroendocrine tumors: Version 9 American Joint Committee on Cancer staging system for gastroenteropancreatic neuroendocrine tumors.

205. Leveraging Programmatic Collaboration for a Radiopharmaceutical Clinic.

206. Exosomal Dynamics and Brain Redox Imbalance: Implications in Alzheimer's Disease Pathology and Diagnosis.

207. Development and validation of a chromatin regulator signature for predicting prognosis hepatocellular carcinoma patient.

208. A feasibility (pilot) mixed methods study of an innovative non-pharmacological breath-based yoga and social-emotional intervention program in an at-risk youth sample in London, Canada.

209. Role of CDK4/6 inhibitors in targeting Rb proficient small cell lung cancer.

210. Berzosertib Plus Topotecan vs Topotecan Alone in Patients With Relapsed Small Cell Lung Cancer: A Randomized Clinical Trial.

211. Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO Guideline.

212. Review of practice informing data and current state of NCCN consensus guidelines in hepatobiliary cancers.

213. Prescribing Characteristics of Octreotide Immediate-Release and Long-Acting Release in Patients with Neuroendocrine Tumors.

215. Treatment Sequencing Strategies in Advanced Neuroendocrine Tumors: A Review.

216. Real-World Clinical and Patient-Reported Outcomes from the Longitudinal Telotristat Ethyl Treatment Registry of Patients with Neuroendocrine Tumors.

217. Pediatric Neuroendocrine Neoplasms: Rare Malignancies with Incredible Variability.

218. Evolving role of seneca valley virus and its biomarker TEM8/ANTXR1 in cancer therapeutics.

219. Comprehensive Assessment of Somatostatin Receptors in Various Neoplasms: A Systematic Review.

220. An Update on the Management of Mixed Neuroendocrine-Non-neuroendocrine Neoplasms (MiNEN).

221. External Validation of a Clinical Score for Patients With Neuroendocrine Tumors Under Consideration for Peptide Receptor Radionuclide Therapy.

222. 68 Ga-DOTATATE PET/CT: The Optimum Standardized Uptake Value (SUV) Internal Reference.

223. Can an amino acid mixture alleviate gastrointestinal symptoms in neuroendocrine tumor patients?

224. Immunotherapy for Medulloblastoma: Current Perspectives.

225. Biliary tract large cell neuroendocrine carcinoma: current evidence.

226. Can a High-grade Neuroendocrine Carcinoma be Functional?

227. Management of Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia: Review and a Single Center Experience.

228. Management of pulmonary neuroendocrine tumors.

229. Neuroendocrine tumors (NETs) of unknown primary: is early surgical exploration and aggressive debulking justifiable?

230. Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia (DIPNECH) and the Role of Somatostatin analogs: A Case Series.

231. Adjuvant intraoperative post-dissectional tumor bed chemotherapy-A novel approach in treating midgut neuroendocrine tumors.

232. Transition of a pancreatic neuroendocrine tumor from ghrelinoma to insulinoma: a case report.

233. Management of immune thrombocytopenic purpura: an update.

234. Cisplatin and cranial irradiation-related hearing loss in children.

235. Younger women are affected by breast cancer in South India - a hospital-based descriptive study.

236. Effective management of pain in pediatric hematology and oncology.

Catalog

Books, media, physical & digital resources